-
Unlike other monoclonal antibody therapies, Evusheld is not meant to treat active coronavirus infection. Instead, it's preventative medicine for people with compromised immune systems.
-
The fight between Florida Gov. DeSantis and the federal government over COVID-19 hit a new chord this week.
-
The roughly 7 million Americans who are immunocompromised — including many people with disabilities — live with much higher risk of COVID-19, and near-constant vigilance.
-
So far the government has distributed nearly 400,000 doses of Evusheld, a new drug that protects against COVID-19. Some 7 million Americans could benefit from the drug right away.
-
Florida monoclonal antibody sites have closed following the U.S. Food and Drug Administration’s announcement that the treatments don’t work against the COVID omicron variant.
-
A third shot of the vaccine can be given at least six months after the two-dose regimen, according to the authorization. A booster rollout could begin this week.
-
President Biden said the U.S. will buy 500 million more vaccine doses. The goal is to vaccinate 70% of the world's population within a year. But more rich nations need to pitch in, he said.
-
DeSantis has been critical of the Biden administration over its COVID-19 mitigation strategies.
-
The governor is touting the monoclonal antibody treatment but is it safe and is it effective? Boca Raton recently enacted the strictest building inspection code in the state. Plus, a battle over the Everglades between sugar companies and the U.S. Army Corps of Engineers.
-
The woman had both the alpha and beta variants of the coronavirus, which were found first in the U.K. and South Africa, respectively.
-
More than a dozen Republican state attorneys general are suing the Biden administration over a provision in the American Rescue Plan that prevents states from using relief money for tax cuts.
-
This post will be updated today, Thursday, June 3, and through the week with the latest information on COVID-19 in South Florida.